United Therapeutics Corp. (UTHR)
513.04
-0.08
(-0.02%)
USD |
NASDAQ |
Aug 24, 16:00
513.04
0.00 (0.00%)
After-Hours: 20:00
United Therapeutics Debt to Equity Ratio : 0.00 for June 30, 2026
Debt to Equity Ratio Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Debt to Equity Ratio Data
| Date | Value |
|---|---|
| June 30, 2026 | 0.00 |
| March 31, 2026 | 0.00 |
| December 31, 2025 | 0.00 |
| September 30, 2025 | 0.00 |
| June 30, 2025 | 0.00 |
| March 31, 2025 | 0.0294 |
| December 31, 2024 | 0.0466 |
| September 30, 2024 | 0.0656 |
| June 30, 2024 | 0.0878 |
| March 31, 2024 | 0.1124 |
| December 31, 2023 | 0.117 |
| September 30, 2023 | 0.1401 |
| June 30, 2023 | 0.1478 |
| March 31, 2023 | 0.1562 |
| December 31, 2022 | 0.1668 |
| September 30, 2022 | 0.1754 |
| June 30, 2022 | 0.1853 |
| March 31, 2022 | 0.1916 |
| December 31, 2021 | 0.2021 |
| September 30, 2021 | 0.2089 |
| June 30, 2021 | 0.2198 |
| March 31, 2021 | 0.2322 |
| December 31, 2020 | 0.2356 |
| September 30, 2020 | 0.2437 |
| June 30, 2020 | 0.2586 |
| Date | Value |
|---|---|
| March 31, 2020 | 0.2713 |
| December 31, 2019 | 0.3074 |
| September 30, 2019 | 0.3699 |
| June 30, 2019 | 0.4118 |
| March 31, 2019 | 0.4521 |
| December 31, 2018 | 0.089 |
| September 30, 2018 | 0.0922 |
| June 30, 2018 | 0.0967 |
| March 31, 2018 | 0.1047 |
| December 31, 2017 | 0.1179 |
| September 30, 2017 | 0.1197 |
| June 30, 2017 | 0.1393 |
| March 31, 2017 | 0.00 |
| December 31, 2016 | 0.00 |
| September 30, 2016 | 0.00 |
| June 30, 2016 | 0.0005 |
| March 31, 2016 | 0.0031 |
| December 31, 2015 | 0.0034 |
| September 30, 2015 | 0.0203 |
| June 30, 2015 | 0.0307 |
| March 31, 2015 | 0.1045 |
| December 31, 2014 | 0.1009 |
| September 30, 2014 | 0.2445 |
| June 30, 2014 | 0.3067 |
| March 31, 2014 | 0.2179 |
Debt to Equity Ratio Definition
The debt to equity ratio measures the (Long Term Debt + Current Portion of Long Term Debt) / Total Shareholders' Equity. This metric is useful when analyzing the health of a company's balance sheet.
Debt to Equity Ratio Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Debt to Equity Ratio Benchmarks
| Liquidia Corp. | 0.9374 |
| Insmed, Inc. | 0.9865 |
| MannKind Corp. | -6.494 |
| Vertex Pharmaceuticals, Inc. | 0.0977 |
| BioMarin Pharmaceutical, Inc. | 0.6672 |
Debt to Equity Ratio Related Metrics
| Total Assets (Quarterly) | 7.220B |
| Total Liabilities (Quarterly) | 819.80M |
| Shareholders Equity (Quarterly) | 6.400B |
| Current Ratio | 5.732 |
| Net Debt Paydown Yield | 0.17% |